hasPharmacokinetics

17 triples
GPTKB property

Random triples
Subject Object
gptkb:DB08868 rapid absorption, peak plasma concentration in 2-4 hours
gptkb:DB15054 Extensively metabolized to active nucleoside analog triphosphate
gptkb:DB00065 Onset 30-60 min, peak 2-4 h, duration 6-8 h
gptkb:DB12189 rapidly converted to active nucleoside analog GS-441524
gptkb:DB14148 prodrug, converted to active nucleoside triphosphate
gptkb:CHEMBL1161 does not cross blood-brain barrier significantly
gptkb:CHEMBL3529 inhibits CYP3A4
gptkb:DB11799 rapidly distributed and metabolized
gptkb:DB09145 peak plasma concentration in 3-4 hours
gptkb:DB13904 rapidly metabolized to active nucleoside analog
gptkb:DB11162 not systemically distributed
gptkb:DB01590 rapid absorption, low bioavailability, renal excretion
gptkb:CHEMBL3529 inhibits CYP2D6
gptkb:CHEMBL1161 low lipid solubility
gptkb:DB12173 prodrug, rapidly metabolized to active nucleoside analog
gptkb:DB15101 Rapidly distributed and metabolized
gptkb:DB13162 extensively metabolized